UK plans Palantir NHS contract extension amid future rebid

Traders Union
All News
Business & Wealth
Companies
UK extends Palantir NHS contract

Highlights

UK ministers plan to extend Palantir's £330mn NHS data platform contract, deeming it impractical to remove the company within four months.
Officials will launch a fresh procurement process for the Federated Data Platform, testing British market interest to address reliance on a single supplier.
The extension and review test the cabinet's buy British agenda and require Palantir to re-bid on equal terms, amid political scrutiny over sovereignty and trust.

NHS contract review and extension plan

As first reported by the Financial Times, ministers are close to signing off a plan to extend Palantir's £330mn NHS contract while designing a longer-term competition for the data platform. People familiar with the matter say a government review has concluded it is not practical to remove the company from NHS data systems within the next four months.

The review began earlier this year ahead of the February break clause and has also gathered NHS feedback on what should change in the future model. That feedback is set to inform a fresh procurement for the longer-term future of the Federated Data Platform, which links datasets across the health service.

The current contract permits a two-year extension beyond the break clause, with the option of two additional one-year extensions. Officials are also testing market interest among British companies as they seek to avoid the NHS becoming too reliant on a single supplier.

Buy British policy and sector implications

The planned approach marks an early practical test of Prime Minister Andy Burnham's "buy British" agenda and a broader cabinet view that control and sovereignty matter in advanced technology. Ministers are also wary that hostility towards Palantir, linked by critics to its work connected to U.S. immigration enforcement and the Israeli military, could weaken public trust in wider plans to use health data for research and AI-led growth.

Rival suppliers argue they are ready to take over the contract, although Palantir's defenders say switching to an unproven alternative would be a major risk. The company won the contract in 2023 after a process that drew complaints from competitors, and its earlier NHS work during the Covid-19 pandemic is cited by critics as having given it a strong advantage in the later tender.

People familiar with the government's thinking say procurement rules require Palantir to be allowed to bid again on the same terms as other companies, even if the next process is structured differently. Health secretary Yvette Cooper told MPs on Wednesday that the review is being conducted "by the book" and said she wants the NHS to help develop UK sovereign AI in future, while Palantir declined to comment and the Department for Health and Social Care did not respond to a request for comment.

Our earlier coverage of the Bank of England’s push for “bare metal” recovery planning explained how UK regulators want major banks to be able to restore critical services even if core technology is compromised. The article highlighted Sarah Breeden’s warning that AI is amplifying the scale and complexity of cyber attacks, prompting supervisors to demand stronger end-to-end resilience and independent fallback options.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.